NCT02132988

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

An Open Labeled Phase II Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions: Ovarian Cancer
Sponsor: Mackay Memorial Hospital
Collaborator: OBI Pharma, Inc.
Phase II 

NCT02097849

A Phase 3b Study of BG00012's Effect on Vaccination Response in Subjects With Relapsed Forms of Multiple Sclerosis

A Randomized, Open-Label Study to Assess the Effects of BG00012 on the Immune Response to Vaccination and on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Conditions: Mulitple Sclerosis
Sponsor: Biogen Idec
Phase  III

NCT02079480

Study to Evaluate the Safety, Tolerability, PK, and PD of CD40 in Healthy Subjects (CD40 FIH)

Condition: n/a  (Healthy Adults)
Sponsor: Bristol-Myers Squibb
Phase I

NCT02031198

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

Condition: Alzheimer's Disease
Sponsor: Axon Neuroscience SE
Phase I

NCT01911234

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis 

Condition: Rheumatoid Arthritis
Sponsor: NeoVacs
Phase: II 

NCT01850238

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Condition: Alzheimer's Disease
Sponsors: Axon Neuroscience
Phase: I 

NCT01910662

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Pruified Protein Derivative (PPD)

Condition: Dermatitis 
Sponsor: GlaxoSmithKline
Phase: 1

NCT01741038

Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer

Condition: Breast Cancer
Sponsors: Immunovative Therapies
Phase 2
Phase 3 

NCT01644968

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I 

Relates to article in Cancer Research

Characterization of human peripheral and intestinal T-cell responses after mucosal antigen exposure: induction of tolerance vs. immunization by oral administration of KLH

Condition: n/a (Healthy Volunteers)
Sponsor: Charite University Berlin
Phase: n/a